Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stoeck

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|September 29, 2007
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAMSteffen Runz, Sascha Keller, Christian Rupp, et al.
Cancer Letters|December 27, 2005
L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cellsAlexander Stoeck, Sabine Schlich, Yasmin Issa, et al.
Lancet (London, England)|September 19, 2003
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasMina Fogel, Paul Gutwein, Sabine Mechtersheimer, et al.
Plos One|May 9, 2012
Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sitesMichelle M Thiaville, Alexander Stoeck, Li Chen, et al.
The Biochemical Journal|October 19, 2005
A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44Alexander Stoeck, Sascha Keller, Svenja Riedle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
The Journal of Biological Chemistry|September 27, 2007
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding eventsMarcia L Moss, Martha Bomar, Qian Liu, et al.
International Journal of Cancer|February 11, 2005
L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomasDaniela Gast, Svenja Riedle, Svenja Riedle, et al.
Molecular Cancer Therapeutics|June 4, 2016
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.
European Journal of Medicinal Chemistry|July 24, 2021
Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancerVladimir Simov, Michael D Altman, Elisabetta Bianchi, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|September 29, 2007
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAMSteffen Runz, Sascha Keller, Christian Rupp, et al.
Cancer Letters|December 27, 2005
L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cellsAlexander Stoeck, Sabine Schlich, Yasmin Issa, et al.
Lancet (London, England)|September 19, 2003
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasMina Fogel, Paul Gutwein, Sabine Mechtersheimer, et al.
Plos One|May 9, 2012
Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sitesMichelle M Thiaville, Alexander Stoeck, Li Chen, et al.
The Biochemical Journal|October 19, 2005
A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44Alexander Stoeck, Sascha Keller, Svenja Riedle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsPaul Gutwein, Alexander Stoeck, Svenja Riedle, et al.
The Journal of Biological Chemistry|September 27, 2007
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding eventsMarcia L Moss, Martha Bomar, Qian Liu, et al.
International Journal of Cancer|February 11, 2005
L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomasDaniela Gast, Svenja Riedle, Svenja Riedle, et al.
Molecular Cancer Therapeutics|June 4, 2016
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.
European Journal of Medicinal Chemistry|July 24, 2021
Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancerVladimir Simov, Michael D Altman, Elisabetta Bianchi, et al.
Pageof 3